Filtros de búsqueda

Lista de obras de David P. Steensma

"Pawn Ball Megakaryocytes": from the marvellous medici and dear Old Saint Nick to the unsanctified marrow of myelodysplasia

artículo científico publicado en 2003

80-year-old woman with dizziness

scientific article published on 01 August 1997

A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)

artículo científico publicado en 2016

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial ⬇️

artículo científico publicado en 2015

A Novel Model to Predict Outcome of Patients with Myelodysplastic Syndromes (MDS) at the Time of Hypomethylating Agent Failure ⬇️

artículo científico publicado en 2015

A Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week Epoetin Alfa and Every-3-Week Darbepoetin Alfa: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC). ⬇️

scholarly article

A Randomized Phase II Study of Low-Dose Decitabine Versus Azacitidine in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes: A Report on Behalf of the MDS Clinical Research Consortium ⬇️

artículo científico publicado en 2016

A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials

artículo científico publicado en 2017

A cello for Michayla

artículo científico publicado en 2010

A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets

artículo científico publicado en 2013

A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.

artículo científico publicado en 2001

A history of the kidney in plasma cell disorders.

artículo científico publicado en 2007

A novel 5' ATRX mutation with splicing consequences in acquired alpha thalassemia-myelodysplastic syndrome.

artículo científico publicado en 2005

A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria.

artículo científico publicado en 2009

A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome.

artículo científico publicado en 2006

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome

artículo científico publicado en 2014

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

artículo científico publicado en 2017

A piece of my mind. The road warriors

artículo científico publicado en 2011

A premature obituary for erythropoietin analogues

artículo científico publicado en 2008

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia

artículo científico publicado en 2015

A randomized phase II study of low-dose decitabine versus low-dose azacitidine in lower risk MDS and MDS/MPN.

artículo científico publicado en 2017

ACP Journal Club. Anemia was independently associated with mortality in very old persons

scientific article published on 01 December 2009

Abbie Lathrop, the "mouse woman of Granby": rodent fancier and accidental genetics pioneer

artículo científico publicado en 2010

Aberrant Splicing In Patients With AML Is Associated With Over- Expression Of Specific Splicing Factors ⬇️

artículo científico publicado en 2013

Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes.

artículo científico publicado en 2008

Absence of frataxin mutations in refractory anemia with ring sideroblasts (RARS)

artículo científico publicado en 2008

Absence of mutations in the key megakaryocyte transcriptional regulator FOG-1 in patients with idiopathic myelofibrosis

artículo científico publicado en 2004

Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies

artículo científico publicado en 2005

Acquired somatic ATRX mutations in myelodysplastic syndrome associated with α thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations ⬇️

artículo científico publicado el 30 de octubre de 2003

Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia

artículo científico publicado en 2015

Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts

artículo científico publicado en 2016

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

artículo científico publicado en 2014

Adolf Butenandt--Nobel Prize for chemistry

artículo científico publicado en 2012

Adolf Lorenz - The Bloodless Surgeon of Vienna

artículo científico publicado en 2017

Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin.

artículo científico publicado en 2010

Albert Sabin--conqueror of poliomyelitis

artículo científico publicado en 2011

Albert Schweitzer: Humanitarian With a "Reverence for Life"

scientific article published on 01 July 2019

Aleksandr Prokhorov--lasers and masers

artículo científico publicado en 2011

Alexander Todd--British Nobel laureate

artículo científico publicado en 2012

Alexandre Yersin: Discoverer of the Plague Bacillus

artículo científico publicado en 2020

Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial

artículo científico publicado en 2019

Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?

artículo científico

Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission

artículo científico publicado en 2016

Alois Alzheimer--Alzheimer disease

artículo científico publicado en 2013

Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome

artículo científico publicado en 2001

An Analysis of Prognostic Markers and the Performance of Scoring Systems in 1837 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS) ⬇️

scholarly article

An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome.

artículo científico publicado en 2007

An Open-Label, Phase 2, Dose-Finding Study of Sotatercept (ACE-011) in Patients with Low or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndromes (MDS) or Non-Proliferative Chronic Myelomonocytic Leukemia (CMML) and Anemia Requiring Transfusion ⬇️

artículo científico publicado en 2014

An RNA bestiary in splicing-mutant MDS

scientific article published on 01 September 2018

An extreme example of focal bone marrow involvement in acute myeloid leukemia

artículo científico publicado en 2012

An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study

scientific article published on 01 April 2019

Andreas Vesalius and De Fabrica

artículo científico publicado en 2019

Anemia in the elderly: how should we define it, when does it matter, and what can be done?

artículo científico publicado en 2007

Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.

artículo científico publicado en 2009

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome

artículo científico publicado en 2002

Antonius Mathijsen and Plaster Casts.

artículo científico publicado en 2017

Are myelodysplastic syndromes "cancer"? Unexpected adverse consequences of linguistic ambiguity

artículo científico publicado en 2006

Art of oncology: new voices wanted

artículo científico publicado en 2011

Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine

artículo científico publicado en 2009

Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasis

scientific article published on 01 August 2000

Baron Aarnoud van Heemstra, Humanitarian Governor of Suriname and Grandfather of Audrey Hepburn

artículo científico publicado en 2019

Barry James Marshall-Discovery of Helicobacter pylori as a Cause of Peptic Ulcer

artículo científico publicado en 2016

Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey.

artículo científico publicado en 2018

Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients

scientific article published on 01 January 2014

Blood vessels everywhere, but so few cells to fill them

artículo científico publicado en 2006

Bone marrow niches in haematological malignancies

artículo científico publicado en 2020

Boulevard of broken dreams: drug approval for older adults with acute myeloid leukemia

artículo científico publicado en 2012

Bruce Beutler: innate immunity and Toll-like receptors

artículo científico publicado en 2014

C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.

artículo científico publicado en 2006

Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?

artículo científico

Cancer research in the United States: A critical review of current status and proposal for alternative models

scientific article published on 14 May 2018

Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts).

artículo científico publicado en 2006

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.

artículo científico publicado en 2013

Caring for the whole patient: the science of psychosocial care

artículo científico publicado en 2012

Catherine Verfaillie--stem cell researcher

artículo científico publicado en 2012

Cecilia Makiwane--pioneer African nurse

artículo científico publicado en 2005

Charles F. Kettering-medical philanthropist and inventor

artículo científico publicado en 2012

Charles Fletcher, The Centaur Company, and Proprietary Medicine Revenue Stamps

artículo científico publicado en 2017

Charles K. Kao—father of fiber optics

artículo científico publicado en 2011

Charles Townes—nobel laureate for maser-laser work

artículo científico publicado en 2011

Christian Albert Theodor Billroth: Founder of Abdominal Surgery

artículo científico publicado en 2018

Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.

artículo científico publicado en 2007

Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed

artículo científico publicado en 2001

Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis

artículo científico publicado en 2018

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced Remission ⬇️

artículo científico publicado en 2011

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination In AML Patients ⬇️

scholarly article

Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia

artículo científico publicado en 2016

Clinicopathologic and genetic characterization of nonacute -mutated myeloid neoplasms

artículo científico publicado en 2019

Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia

artículo científico publicado en 2018

Clonal Hematopoiesis and Measurable Residual Disease Assessment in Acute Myeloid Leukemia

scientific article published on 13 March 2020

Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week

scientific article published on 01 July 2019

Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?

artículo científico publicado en 2003

Clonal hematopoiesis as a model for premalignant changes during aging

scientific article published on 12 December 2019

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

artículo científico publicado en 2020

Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

artículo científico publicado en 2015

Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey

artículo científico publicado en 2007

Comparing The Prognostic Value Of Risk Stratifying Models For Patients With Lower-Risk Myelodysplastic Syndromes (MDS): Is One Model Better? A Report on The Behalf of The MDS Clinical Research Consortium ⬇️

artículo científico publicado en 2013

Comparing the Prognostic Value of Risk stratifying Models for Patients with Lower-Risk Myelodysplastic Syndromes: Is one model better?

artículo científico publicado en 2015

Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?

artículo científico publicado en 2015

Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium

artículo científico publicado en 2017

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides.

artículo científico publicado en 2015

Compassionate honesty

scientific article published on 01 October 2010

Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment outcomes with imatinib mesylate.

artículo científico publicado en 2003

Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia

artículo científico publicado en 2005

Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria

artículo científico publicado en 2006

Congenital sideroblastic anemia associated with germline polymorphisms reducing expression of FECH

artículo científico publicado en 2008

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study

artículo científico publicado en 2016

Contract research organizations in oncology clinical research: Challenges and opportunities

artículo científico publicado en 2016

Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder

artículo científico publicado en 2012

Cytogenetic and molecular genetic aspects of essential thrombocythemia

artículo científico publicado en 2002

Cytopenias + mutations - dysplasia = what?

artículo científico publicado en 2015

DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions ⬇️

scholarly article

De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.

artículo científico publicado en 2014

Decitabine treatment of patients with higher-risk myelodysplastic syndromes

artículo científico publicado en 2009

Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome

artículo científico publicado en 2012

Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment

artículo científico publicado en 2009

Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome

scientific article published on 23 October 2003

Detection of Recurrent Mutations by Pooled Targeted Next-Generation Sequencing in MDS Patients Prior to Treatment with Hypomethylating Agents or Stem Cell Transplantation ⬇️

scholarly article

Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis

artículo científico publicado en 2020

Differences In Perceptions Of Disease and Treatment Effectiveness and Adherence Between Physicians and Patients With Myelodysplastic Syndromes (MDS) ⬇️

scholarly article

Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC).

artículo científico publicado en 2016

Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes

artículo científico publicado en 2014

Does treatment with recombinant human erythropoietin affect the survival of anemic patients with cancer?

artículo científico publicado en 2005

Down syndrome in Down House: trisomy 21, GATA1 mutations, and Charles Darwin

artículo científico publicado en 2005

Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q

artículo científico publicado en 2008

Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors.

artículo científico

Edward L. Trudeau--founder of a sanatorium for treatment of tuberculosis

artículo científico publicado en 2010

Effects of the MEK inhibitor CI-1040 (PD 184352) on progenitor growth from normal and myelodysplastic marrow.

artículo científico publicado en 2003

Elevated serum LDH in patients with non-Hodgkin's lymphoma: not always an ominous sign

artículo científico publicado en 1999

Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis

artículo científico publicado en 2006

Elias James Corey--Nobel Prize for retrosynthetic analysis

artículo científico publicado en 2013

Elizabeth Blackburn and Maintenance of Telomeres

artículo científico publicado en 2016

Enough already of the word "robust"!

scientific article published on 01 January 2004

Epoetin alfa and darbepoetin alfa go head to head

artículo científico publicado en 2006

Ernesto "Che" Guevara de la Serna: Argentinian Marxist Revolutionary

artículo científico publicado en 2015

Erythropoiesis stimulating agents

artículo científico publicado en 2007

Erythropoiesis-stimulating agents are effective in myelodysplastic syndromes, but are they safe?

scientific article published on 01 January 2009

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

artículo científico publicado en 2009

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

artículo científico publicado en 2008

Erythropoietin use in cancer patients: a matter of life and death?

scientific article published on 08 August 2005

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

artículo científico publicado en 2002

Eureka moments

Exacerbation of asthma by Florida "red tide" during an ocean sailing trip

artículo científico publicado en 2007

FLT3 Splice Variant (FLT3Va) As a Potential Immunotherapeutic Target in Patients with Acute Myeloid Leukemia (AML) ⬇️

artículo científico publicado en 2016

Ferid Murad--1998 Nobel laureate for nitric oxide research

artículo científico publicado en 2004

Fernando Figueira: Brazilian Public Health Champion

scientific article published on 01 September 2020

Fifty years of Tart cells

scientific article published on 01 September 1999

Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?

artículo científico publicado en 2020

Flow cytometric methods for detection and quantification of apoptosis.

artículo científico publicado en 2003

Frederick Soddy--pioneer in radioactivity

artículo científico publicado en 2011

Friedrich August Johannes Löffler (Loeffler), German Bacteriologist

artículo científico publicado en 2015

Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.

artículo científico publicado en 2005

Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence

scientific article published on 20 September 2019

Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells

scientific article published on 19 March 2020

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

artículo científico publicado en 2019

George Herman "Babe" Ruth Jr: baseball star and early participant in a cancer clinical trial

artículo científico publicado en 2008

Georges de Bellio (1826-1894): Doctor, Friend, and Patron of the Impressionist Painters

artículo científico publicado en 2019

Geriatric Assessment Variables Add Prognostic Value to the International Prognostic Scoring System ⬇️

artículo científico publicado en 2012

Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes

artículo científico publicado en 2013

Guideline-based indicators for adult patients with myelodysplastic syndromes

scientific article published on 01 August 2020

Hans Geiger-German physicist and the Geiger counter

artículo científico publicado en 2011

Health care utilization and end-of-life care for older patients with acute myeloid leukemia

artículo científico publicado en 2015

Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2(V617F) positive, del(5)(q13q33) myelodysplastic syndrome

artículo científico publicado en 2006

Hematopoietic growth factors in myelodysplastic syndromes

artículo científico publicado en 2011

Hendrik van Deventer: Dutch Obstetrician and Orthopedist.

artículo científico publicado en 2016

Henry David Thoreau's Final Journey: Minnesota

artículo científico publicado en 2018

Hereditary red blood cell disorders in middle eastern patients

artículo científico publicado en 2001

Herman Boerhaave - Master Clinician and Humanist

article

High cancer drug prices in the United States: reasons and proposed solutions

artículo científico publicado en 2014

HighNPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

article

Historical perspectives on myelodysplastic syndromes

artículo científico

History of multiple myeloma

artículo científico publicado en 2011

Horace Magoun--neuroanatomist and neurophysiologist

artículo científico publicado en 2013

Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count

scientific article published on 01 March 2010

How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes

scientific article published on 05 September 2018

Howard Walter Florey-Production of Penicillin

artículo científico publicado en 2015

Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review

artículo científico publicado en 2001

Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities

scientific article published on 20 March 2020

IDH1 Splicing Alterations in Patients with AML and Their Relationship to Blood 2HG Levels ⬇️

artículo científico publicado en 2014

Ian Wilmut--pioneer of cloning

artículo científico publicado en 2013

Ibn Sina (Avicenna): The "Prince of Physicians"

artículo científico publicado en 2020

Imerge: A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) That Is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment ⬇️

artículo científico publicado en 2019

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

artículo científico publicado en 2020

Impact of Cytogenetic Abnormalities and Cytogenetic Response to Hypomethylating Agents (HMAs) in Patients (pts) with Lower Risk Myelodysplastic Syndromes (MDS) ⬇️

artículo científico publicado en 2015

Impact of Hypomethylating Agent Therapy in Myelodysplastic Syndromes with Chromosome 3 Abnormalities ⬇️

artículo científico publicado en 2015

Impact of cancer research bureaucracy on innovation, costs, and patient care

artículo científico publicado en 2014

Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes

artículo científico publicado en 2018

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.

artículo científico publicado en 2018

Incremental gains and a long road ahead in MDS.

artículo científico publicado en 2008

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

artículo científico publicado en 2016

Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes

artículo científico publicado en 2016

Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion

artículo científico publicado en 2013

Insurance Denial of Coverage for Patients Enrolled in Cancer Clinical Trials Is Still a Problem in the Affordable Care Act Era

artículo científico publicado en 2016

Intensified Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): A Phase II Study from the Dana Farber Cancer Institute (DFCI) ALL Consortium ⬇️

scholarly article

Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database

artículo científico publicado en 2016

International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens.

artículo científico publicado en 2011

Investment analysts and the American Society of Hematology

artículo científico publicado en 2008

Is Serial Monitoring of Myeloid Mutations Clinically Relevant in Myelodysplastic Syndromes (MDS): A Report on Behalf of the MDS Clinical Research Consortium (CRC) ⬇️

scholarly article

Is anemia of cancer different from chemotherapy-induced anemia?

scientific article published on 28 January 2008

Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?

artículo científico publicado en 2008

Isidor Rabi-1944 Nobel laureate in physics

artículo científico publicado en 2012

Isolated splenic sinus histiocytosis (Rosai-Dorfman disease) in association with myelodysplastic syndrome

scientific article published on 01 August 2006

Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance.

artículo científico publicado en 2008

J. Robin Warren: Helicobacter Pylori and Peptic Ulcer

artículo científico publicado en 2016

JAK2 V617F and ringed sideroblasts: not necessarily RARS-T.

artículo científico publicado en 2008

JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

artículo científico publicado en 2006

JAK2 V617F in myeloid disorders: what do we know now, and where are we headed?

artículo científico publicado en 2006

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

artículo científico publicado en 2006

James Allison and Cancer Immunotherapy

artículo científico publicado en 2020

James B. Collip--member of the Canadian team that isolated insulin

artículo científico publicado en 2013

Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2006

Jens Skou--nobel prize in chemistry

artículo científico publicado en 2013

John Calvin and Michael Servetus: tragic clash of reformer and radical physician

artículo científico publicado en 2002

John E. Walker—Nobel Prize in chemistry in 1997.

artículo científico publicado en 2015

John Robert Vane--British pharmacologist and Nobel laureate

artículo científico publicado en 2013

John Shaw Billings: Civil War Surgeon, Medical Librarian, Founder of Index Medicus, and First Director of the New York Public Library

artículo científico publicado en 2019

Jöns Jacob Berzelius - A Father of Chemistry

artículo científico publicado en 2018

Kaare Nygaard: Surgeon, Scientist, Sculptor

artículo científico publicado en 2021

Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts.

artículo científico publicado en 2011

Lenalidomide in AML: del(5q) or who?

scientific article published on 01 July 2011

Leopold Ruzicka--1939 Nobel Prize in chemistry.

artículo científico publicado en 2007

Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria

artículo científico publicado en 2008

Littoral cell angioma associated with portal hypertension and resected colon cancer.

artículo científico publicado en 2000

Long-Term Outcome of Myelodysplastic Syndromes (MDS) Patients Treated with Erythropoiesis Stimulating Agents (ESAs) ⬇️

artículo científico publicado en 2015

Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance ⬇️

scholarly article

Low Clinical Trial Accrual of Patients With Myelodysplastic Syndromes: Causes and Potential Solutions

artículo científico publicado en 2018

Low Efficacy and High Mortality Associated with Clofarabine Treatment of Patients with Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes ⬇️

scholarly article

Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes

artículo científico publicado en 2014

Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes

artículo científico publicado en 2020

Low-Dose Hypomethylating Agents (HMAs) Are Effective in Patients (Pts) with Low- or Intermediate-1-Risk Myelodysplastic Syndrome (MDS): A Report on Behalf of the MDS Clinical Research Consortium ⬇️

artículo científico publicado en 2015

Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

Luis Walter Alvarez: another "Mayo-trained" Nobel Laureate

artículo científico publicado en 2006

Luke Fildes and The Doctor

artículo científico publicado en 2019

MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count

scientific article published on 01 December 2006

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

artículo científico publicado en 2006

Management of anemia in patients with cancer

artículo científico publicado en 2004

Max Perutz and the Structure of Hemoglobin

artículo científico publicado en 2015

Michael Servetus: unorthodox theologian, meticulous cartographer, and innovative anatomist

artículo científico publicado en 2013

Monocytic skin nodules in chronic myelomonocytic leukemia: clinical response to decitabine therapy

artículo científico publicado en 2007

More on Myb in myelofibrosis: molecular analyses of MYB and EP300 in 55 patients with myeloproliferative disorders

artículo científico publicado en 2006

Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial

artículo científico publicado en 2009

Mutations in the chromatin-associated protein ATRX.

artículo científico publicado en 2008

Myelodysplasia paranoia: iron as the new radon

artículo científico publicado en 2008

Myelodysplasia with fibrosis: a distinct entity?

artículo científico publicado en 2001

Myelodysplasia, megakaryocytes, and methylation

artículo científico publicado en 2004

Myelodysplastic syndrome and pregnancy: the Mayo Clinic experience

artículo científico publicado en 2001

Myelodysplastic syndrome associated with acquired beta thalassemia: "BTMDS".

artículo científico publicado en 2016

Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that of de novo MDS

scientific article published on 12 November 2019

Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era

artículo científico publicado en 2008

NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML

artículo científico publicado en 2014

Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts

artículo científico publicado en 2008

New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony

scientific article published on 01 November 2007

New Insights from Studies of Clonal Hematopoiesis.

artículo científico publicado en 2018

New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice

artículo científico publicado en 2013

Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

artículo científico publicado en 2013

Nikolay Basov--nobel prize for lasers and masers

artículo científico publicado en 2012

Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults

artículo científico publicado en 2015

North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia ⬇️

artículo científico publicado en 2015

Northwoods elegy

scientific article published on 01 October 2004

Novel therapies for myelodysplastic syndromes

scientific article published on 01 April 2010

Oddballs: acute leukemias of mixed phenotype and ambiguous origin.

artículo científico publicado en 2011

On the TRAIL of a new therapy for leukemia.

artículo científico publicado en 2005

Oncologists' Reluctance to Use the Terms Hope and Cure: A Bibliometric Analysis of Articles From Two High-Impact Oncology Journals

scientific article published on 14 August 2020

Optimal Treatment Order of Lenalidomide and Hypomethylating Agents for Lower-Risk Myelodysplastic Syndromes: A Report on Behalf of the MDS Clinical Research Consortium ⬇️

artículo científico publicado en 2016

Oral cedazuridine/decitabine: a phase 2, pharmacokinetic/pharmacodynamic, randomized, crossover study in MDS and CMML

scientific article published on 13 April 2020

Oscar (Oskar) Minkowski: discovery of the pancreatic origin of diabetes

artículo científico publicado en 2015

Otto Wichterle--Inventor of the First Soft Contact Lenses

artículo científico publicado en 2016

Out of this nettle, danger, we must pluck this flower, safety

scientific article published on 01 September 2009

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

artículo científico publicado en 2017

Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents

artículo científico publicado en 2020

Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: a report on behalf of the MDS Clinical Research Consortium

artículo científico publicado en 2014

Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit ⬇️

artículo científico publicado en 2015

Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission

scientific article published on 12 July 2019

Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents

scientific article published on 22 December 2015

Outdated dogma? Busulfan, seizure prophylaxis, and stem cell allografting

artículo científico publicado en 2012

Overall Survival and Subgroup Analysis from a Randomized Phase III Study of Intravenous Rigosertib Versus Best Supportive Care (BSC) in Patients (pts) with Higher-Risk Myelodysplastic Syndrome (HR-MDS) after Failure of Hypomethylating Agents (HMAs) ⬇️

scholarly article

Overcoming obstacles to hospice care: an ethical examination of inertia and inaction

artículo científico publicado en 2003

Overcoming obstacles to hospice care: an ethical examination of inertia and inaction

artículo científico publicado en 2002

P39/Tsugane cells are a false cell line contaminated with HL-60 cells and are not suitable for mechanistic studies in myelodysplastic syndromes

artículo científico publicado en 2010

Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia

scientific article published on 23 August 2018

Patient-Reported Outcomes Associated with Different Treatments for Myelodysplastic Syndromes ⬇️

scholarly article

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life

artículo científico publicado en 2014

Patients over Age 40 with Ph-Negative Acute Lymphoblastic Leukemia Do Not Benefit from Allogeneic Transplant in First Remission. Retrospective Analysis from a Large Tertiary Center ⬇️

artículo científico publicado en 2015

Patients with haematological malignancies should not have to choose between transfusions and hospice care

scientific article published on 01 May 2020

Paul D. Boyer—Nobel prize for work on ATP synthase

artículo científico publicado en 2011

Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey

artículo científico publicado en 2011

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

artículo científico publicado en 2012

Phase 1b/2 Combination Study of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) ⬇️

scholarly article

Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia

artículo científico

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia

artículo científico publicado en 2011

Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

scientific article published on 15 June 2013

Phase II Clinical Trial of Alisertib, an Aurora a Kinase Inhibitor, in Combination with Induction Chemotherapy in High-Risk, Untreated Patients with Acute Myeloid Leukemia ⬇️

artículo científico publicado en 2018

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer

scientific article published on 01 March 2006

Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia

artículo científico publicado en 2010

Physician-poet William Carlos Williams--"no ideas but in things".

artículo científico publicado en 2014

Platelet count is an IPSS-independent risk factor predicting survival in refractory anaemia with ringed sideroblasts

artículo científico publicado en 2008

Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia I ultrastructure

artículo científico publicado en 2007

Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia II. Cytochemistry

artículo científico publicado en 2007

Polycythemia vera: plethora, from prehistory to present.

artículo científico publicado en 2005

Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder

artículo científico publicado en 2008

Potential Barriers to Clinical Trials of New Therapeutics for Myelodysplastic Syndromes: Wide Variation in Risk Definitions and Trial Enrollment Criteria ⬇️

artículo científico publicado en 2018

Potentially Avoidable Hospitalizations in Older Patients with Acute Myeloid Leukemia (AML) ⬇️

artículo científico publicado en 2015

Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis

artículo científico publicado en 2016

Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes

artículo científico publicado en 2010

Preliminary International Validation of the Quality of Life in Myelodysplasia Scale (QUALMS) ⬇️

artículo científico publicado en 2014

Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders

artículo científico publicado en 2007

Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases

artículo científico publicado en 2008

Prince Wongsa Dhiraj Snid--Thai physician and diplomat

artículo científico publicado en 2012

Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.

artículo científico publicado en 2007

Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R

scientific article published on 26 September 2018

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

artículo científico publicado en 2018

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

artículo científico publicado en 2017

Prospective Cohort Study of Geriatric Assessment in Older Patients with Acute Myeloid Leukemia ⬇️

artículo científico publicado en 2012

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS).

artículo científico publicado en 2016

Prospects and perils of retrospective risk assessment of erythropoiesis-stimulating agents.

artículo científico publicado en 2008

Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience

artículo científico publicado en 2006

Putting it all together in CMML risk stratification

artículo científico publicado en 2016

Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML) ⬇️

artículo científico publicado en 2018

Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy

artículo científico publicado en 2019

RAD51 and XRCC3 polymorphism frequency and risk of myelodysplastic syndromes

artículo científico publicado en 2008

Razi: Critical Thinker, and Pioneer of Infectious Disease and Ophthalmology

scientific article published on 01 May 2020

Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes

artículo científico publicado en 2020

Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes.

artículo científico publicado en 2009

Reassurance

artículo científico publicado en 2004

Recent developments in myelodysplastic syndromes.

artículo científico publicado en 2014

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

artículo científico publicado en 2009

Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.

artículo científico publicado en 2009

Relationship of Bone Marrow Blast (BMBL) Response to Overall Survival (OS) in Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) Treated with Rigosertib after Failure of Hypomethylating Agents (HMAs) ⬇️

artículo científico publicado en 2014

Reply to H. Kantarjian et al.

artículo científico publicado en 2013

Response to Treatment Among SF3B1 Mutated Myelodysplastic Syndromes (MDS): A Case-Control Study from the MDS Clinical Research Consortium (MDS CRC) ⬇️

artículo científico publicado en 2015

Results of First in Human (FIH) Phase 1 Pharmacokinetic (PK) Guided Dose-Escalation Study of ASTX727, a Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine in Subjects with Myelodysplastic Syndromes (MDS) ⬇️

artículo científico publicado en 2015

Review: epoetin and darbepoetin reduce need for blood transfusions but increase risk for thrombosis in patients with cancer.

artículo científico publicado en 2008

Richard Ernst--Nobel Prize for nuclear magnetic resonance spectroscopy

artículo científico publicado en 2012

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

artículo científico publicado en 2016

Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

scientific article published on 18 October 2017

Risk-based management of myelodysplastic syndrome

artículo científico publicado en 2007

Roald Dahl: Children's Book Author, Medical Device Inventor, Myelodysplastic Syndrome Patient, and Philanthropist

artículo científico publicado en 2020

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

artículo científico publicado en 2011

SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM)

artículo científico publicado en 2020

Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States

artículo científico publicado en 2018

Self-reported sleep disturbance and survival in myelodysplastic syndromes

artículo científico publicado en 2017

Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia

artículo científico publicado en 2015

Severe coagulation factor V deficiency associated with an interstitial deletion of chromosome 1q

scientific article published on 13 December 2006

Short Telomere Length Predicts Non-Relapse Mortality after Stem Cell Transplantation for Myelodysplastic Syndrome

artículo científico publicado en 2020

Should oncologists support the Affordable Care Act?

artículo científico publicado en 2013

Sidney Altman--Nobel laureate for work with RNA

artículo científico publicado en 2012

Sir Brian Gerald Barratt-Boyes-pioneer cardiac surgeon

artículo científico publicado en 2012

Sir Charles Sherrington--"The William Harvey of the nervous system".

artículo científico publicado en 2005

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation

artículo científico publicado en 2014

Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia

scientific article published on 01 January 2005

Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial

artículo científico publicado en 2018

Speaking a common language in MDS/MPNs

artículo científico publicado en 2015

Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic

scientific article published on 30 April 2020

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

scientific article published on 18 June 2020

Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome

artículo científico publicado en 2003

Stamp vignette on medical science. Daniel Alcides Carrión--Peruvian hero and medical martyr

artículo científico publicado en 2014

Stamp vignette on medical science. Nicolae Testemiţanu-Moldovan surgeon, scientist, and politician

artículo científico publicado en 2014

Stamp vignette on medical science. Robert F. Curl Jr-Nobel Laureate in Chemistry

artículo científico publicado en 2010

Stamp vignette on medical science. Vincent du Vigneaud-Nobel Prize in chemistry

artículo científico publicado en 2013

Stamp vignette on medical science. William F. Giauque--Nobel Prize for low-temperature research

artículo científico publicado en 2006

Stories we tell one another: narrative reflection and the art of oncology.

artículo científico

Stress-induced hematopoietic failure in the absence of immediate early response gene X-1 (IEX-1, IER3)

artículo científico publicado en 2013

Submitting to Autonomy ⬇️

artículo científico publicado el 1 de mayo de 2003

Survival after Hematopoietic Stem Cell Transplantation in an Older, Fit Cohort of Patients with Advanced Myelodysplastic Syndromes: The MDS-TAO Study ⬇️

artículo científico publicado en 2018

Susumu Tonegawa--Japan's first Nobel laureate in physiology or medicine

artículo científico publicado en 2011

Symptom control trials: a 20-year experience.

artículo científico publicado en 2007

Systematic STAT3 Mutation Testing Identifies Patients with Unsuspected T-Cell Large Granular Lymphocytic Leukemia ⬇️

artículo científico publicado en 2016

Systematic sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia

scientific article published on 13 September 2017

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

artículo científico publicado en 2014

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

scientific article published on 11 January 2019

Tadeus Reichstein-work on hormones of the adrenal glands

artículo científico publicado en 2013

Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.

artículo científico publicado en 2016

Terry Fox: Canadian cancer research activist whose "Marathon of Hope" inspired millions

artículo científico publicado en 2014

Thalassemia and Thomas Benton Cooley

artículo científico publicado en 2017

The 1964 "Doctors Mayo" commemorative postage stamp

artículo científico publicado en 2014

The Blood of the Lamb.

artículo científico publicado en 2009

The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor

scientific article published on 27 May 2020

The Hippocratic Oath, the US Health Care System, and the Affordable Care Act in 2015.

artículo científico publicado en 2015

The In-Training Examination in Internal Medicine

scientific article published on 01 June 2003

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

artículo científico publicado en 2005

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

artículo científico publicado en 2005

The Medical Doctors of Star Trek: Leonard "Bones" McCoy and Beverly Crusher

artículo científico publicado en 2017

The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

artículo científico publicado en 2009

The Narrow Path ⬇️

artículo científico publicado el 1 de mayo de 2003

The Patient Protection and Affordable Care Act: Is it good or bad for oncology?

artículo científico publicado en 2014

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

The Role of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Multiple Myeloma: Immunomodulator Maintenance Post Autologous Stem Cell Transplant (ASCT) Predicts Better Outcome ⬇️

scholarly article

The Role of Iron Chelation Therapy for Patients With Myelodysplastic Syndromes ⬇️

artículo científico publicado el 1 de enero de 2011

The Scent of Cancer ⬇️

artículo científico publicado el 3 de agosto de 2010

The art and science of prognosis in patients with advanced cancer

scientific article published on 01 October 2000

The art of oncology: when the tumor is not the target. Don't mention it.

artículo científico publicado en 2008

The beginning of the end of the beginning in cancer genomics

artículo científico publicado en 2013

The bone-marrow niche in MDS and MGUS: implications for AML and MM.

artículo científico publicado en 2018

The changing classification of myelodysplastic syndromes: what's in a name?

artículo científico publicado en 2009

The chronic myeloproliferative disorders: an historical perspective.

artículo científico publicado en 2003

The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

artículo científico publicado en 2016

The kiss of death: a severe allergic reaction to a shellfish induced by a good-night kiss

scientific article published on 01 February 2003

The molecular pathogenesis of myelodysplastic syndromes

scientific article published on 05 August 2010

The mosaic of myeloid neoplasia: implications for classification

artículo científico publicado en 2008

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

artículo científico publicado en 2003

The myelodysplastic syndromes: diagnosis and treatment

artículo científico publicado en 2006

The ordinary miracle of cancer clinical trials

artículo científico publicado en 2009

The other résumé

artículo científico publicado en 2002

The questions of prognosis.

artículo científico publicado en 2005

The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debate

artículo científico publicado en 2011

The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia

artículo científico publicado en 2007

The symbol of modern medicine

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

artículo científico publicado en 2018

The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group.

artículo científico publicado en 2005

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

artículo científico publicado en 2020

Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

artículo científico publicado en 2017

Thrombopoiesis-stimulating agents and myelodysplastic syndromes

artículo científico publicado en 2015

Thrombosis in Myeloproliferative Neoplasms Is Linked to Increased Neutrophil Extracellular Trap (NET) Formation ⬇️

scholarly article

Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis

artículo científico publicado en 2021

Tuning the rigging before sailing off into the stormy sea of stem cell transplants for patients with myelodysplastic syndromes

artículo científico publicado en 2012

Use of an Electronic Medical Record (EMR) Database to Identify a Real-World Cohort of US Patients (Pts) with Myelodysplastic Syndromes (MDS) ⬇️

scholarly article

VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia

artículo científico publicado en 2008

Validation of International Working Group (IWG) Response Criteria in Higher-Risk Myelodysplastic Syndromes (MDS): A Report on Behalf of the MDS Clinical Research Consortium (MDS CRC) ⬇️

artículo científico publicado en 2015

Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

artículo científico publicado en 2020

Validation of a Prognostic Model and the Impact of SF3B1, DNMT3A, and Other Mutations in 289 Genetically Characterized Lower Risk MDS Patient Samples ⬇️

scholarly article

Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care

artículo científico publicado en 2017

Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes

artículo científico publicado en 2012

Van Gogh's Portrait of Dr Gachet

artículo científico publicado en 2017

Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors

artículo científico

Walter Clement Noel—First Patient Described With Sickle Cell Disease ⬇️

artículo científico publicado el 1 de octubre de 2010

Walter Hess—Nobel Prize for work on the brain

artículo científico publicado en 2011

Werner Forssmann: A Pioneer of Interventional Cardiology and Auto-Experimentation

artículo científico publicado en 2018

What To Tell Your Patient With Clonal Hematopoiesis And Why: Insights From Two Specialized Clinics

artículo científico publicado en 2020

When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?

artículo científico publicado en 2013

Why does my patient have lymphadenopathy or splenomegaly?

artículo científico publicado en 2012

Why me?

artículo científico publicado en 2003

Why me?

artículo científico publicado en 2002

Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients with Myelodysplastic Syndromes (MDS): Results of a Large Web-Based Survey ⬇️

scholarly article

Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey

artículo científico publicado en 2020

Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States

artículo científico publicado en 2016

Wilberforce J. J. Arnold--"St. Helena's Greatest Friend".

artículo científico publicado en 2014

William Murphy--Nobel Prize for the treatment of pernicious anemia

artículo científico publicado en 2006

William Shockley and the transistor

artículo científico publicado en 2012

Working against the grain

scientific article published on 01 May 2006

X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation

artículo científico publicado en 2020

Álvaro Alvim-Radiologist and Brazilian "Martyr to Science".

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda